Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Fountain Pharmaceuticals (FPHI) -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (72)	2/16/2001 5:23:19 PM
From: scaram(o)uche	Respond to of 78

seems like a fit, given Fisner et al. and other issues...... Subject 11582 sibob.com Medix Resources CTO Resigns; Company Poised to Continue Strong Business Momentum NEW YORK, Feb. 16 /PRNewswire/ -- Medix Resources, Inc. (Amex: MXR) today announced the resignation of Mr. David Pfeil from his position as Medix Executive Vice President and Chief Technology Officer, his position as a member of the Medix Board of Directors, and his positions as President and COO and a director of the Medix subsidiary, Cymedix Lynx Corporation. Mr. Pfeil has stated that he has resigned to pursue other opportunities and to spend more time with his family. Pursuant to Mr. Pfeil's contract amendment, announced in December, Medix Resources will retain Mr. Pfeil's services as a consultant for up to 120 days to ensure a smooth transition in the Company's day-to-day technology operations. Mr. Prufeta, Medix President and CEO, commented, "We are grateful for Mr. Pfeil's contribution to our company, especially in its formative stages, and we certainly wish him well in his future endeavors. Today, we believe that Medix is in a strong competitive position on the technology front, which has enabled us to advance to the next phase of the Company's development in capitalizing on the substantial market opportunity ahead of us. This progress is reflected in the number of contracts that are currently under negotiations, as well as in our advancing sales pipeline. We expect to hire a temporary CTO to work with Mr. Pfeil on the immediate transition, while we search for a permanent CTO replacement suitable for our next phase of growth. We are confident that Medix will attract a high quality technology executive to further strengthen our management team." About Medix Resources, Inc. Medix Resources, Inc. through its wholly owned subsidiary Cymedix Lynx Corporation is the developer and provider of the Cymedix(R) suite of fully-secure, patented Internet based software products, that will allow instantaneous communication of high value added healthcare information among doctor offices, hospitals, health management organizations and insurance companies. Additional information about Medix Resources and its products and services can be found by visiting its Web sites, medixresources.com and cymedix.com or by calling (800) 326-8773. Information in this press release contains forward-looking statements that involve risks and uncertainties that might adversely affect the Company's operating results in the future to a material degree. Such risks and uncertainties include, without limitation, the ability of the Company to raise capital to finance the development of its software products, the effectiveness and the marketability of those products, the ability of the Company to protect its proprietary information, and the establishment of an efficient corporate operating structure as the Company grows. These and other risks and uncertainties are presented in detail in the Company's Form 10-KSB for 1999, and its Form 10-QSB for the third quarter of 2000, which were filed with the Securities and Exchange Commission on March 30, 2000, and November 14, 2000, respectively. This information is available from the SEC or the Company. SOURCE Medix Resources, Inc. Web Site: medixresources.com